Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

AMLX

Amylyx Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · AMLX

All alert types
28.86 USD +0.18 +0.63%
As of Oct 30, 2026 Extended hours 28.86 0.00%
Bid
28.85 × 2
Ask
28.86 × 2
28.00 Day range 29.09
11.38 52-week range 39.66
YTD
+138.91%
1 year
+105.41%
Open
28.41
Prev close
28.68
Mkt cap
3.62B
Vol
989.52K
Avg vol
2.21M
EPS
-1.41
P/E
0.00
Div yield
0.00%
More statistics
Low
28.00
High
29.09
Forward P/E
-26.47
Beta
-0.09
Short ratio
9.49
Inst. own
94.37%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
31.11
200-d avg
20.00
1y target
43.00

5D chart

Chart tools
Interval
1m5m15m30m
AMLX five-day price chart26.227.027.728.429.1Oct 23Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

80.35 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -7.9×
FY 2019: -69.5×FY 2020: -22.9×FY 2021: -11.9×FY 2022: -12.4×FY 2023: 20.2×FY 2024: -0.9×FY 2025: -7.9×
FY 2019 5y median -7.9× FY 2025
P/S 0.0×
FY 2019: 716×FY 2020: 1570×FY 2021: 0.0×FY 2022: 111×FY 2023: 2.6×FY 2024: 2.9×FY 2025: 0.0×
FY 2019 5y median 2.6× FY 2025
P/B 3.7×
FY 2019: -40.2×FY 2020: -15.3×FY 2021: -6.9×FY 2022: 7.2×FY 2023: 2.3×FY 2024: 1.6×FY 2025: 3.7×
FY 2019 5y median 2.3× FY 2025
P/FCF -9.3×
FY 2019: -95.5×FY 2020: -27.7×FY 2021: -13.9×FY 2022: -13.5×FY 2023: 92.7×FY 2024: -1.5×FY 2025: -9.3×
FY 2019 5y median -9.3× FY 2025
EV/EBITDA -6.4×
FY 2019: 927×FY 2020: -25.9×FY 2021: -11.3×FY 2022: -12.2×FY 2023: 14.9×FY 2024: -0.6×FY 2025: -6.4×
FY 2019 5y median -6.4× FY 2025
EV/Sales 0.0×
FY 2019: 724×FY 2020: 1552×FY 2021: 0.0×FY 2022: 108×FY 2023: 2.2×FY 2024: 2.1×FY 2025: 0.0×
FY 2019 5y median 2.1× FY 2025
FCF Yield -10.8%
FY 2019: -1.0%FY 2020: -3.6%FY 2021: -7.2%FY 2022: -7.4%FY 2023: 1.1%FY 2024: -65.1%FY 2025: -10.8%
FY 2019 5y median -7.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: -734.4%FY 2020: -3683.7%FY 2021: 0.0%FY 2022: 86.5%FY 2023: 93.3%FY 2024: 51.8%FY 2025: 0.0%
FY 2019 5y median 51.8% FY 2025
Operating Margin 0.0%
FY 2019: -950.5%FY 2020: -6000.8%FY 2021: 0.0%FY 2022: -905.7%FY 2023: 10.2%FY 2024: -360.2%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: -1039.0%FY 2020: -6504.6%FY 2021: 0.0%FY 2022: -892.4%FY 2023: 12.9%FY 2024: -345.4%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -47.4%
FY 2019: 58.4%FY 2020: 63.4%FY 2021: 58.2%FY 2022: -58.2%FY 2023: 11.4%FY 2024: -183.1%FY 2025: -47.4%
FY 2019 5y median -47.4% FY 2025
ROIC -49.3%
FY 2019: 1035.4%FY 2020: -575.5%FY 2021: -93.7%FY 2022: -58.0%FY 2023: 8.0%FY 2024: -188.5%FY 2025: -49.3%
FY 2019 5y median -58.0% FY 2025
ROA -43.5%
FY 2019: -460.1%FY 2020: -299.8%FY 2021: -83.3%FY 2022: -50.7%FY 2023: 9.5%FY 2024: -155.8%FY 2025: -43.5%
FY 2019 5y median -50.7% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2019: 0.0%FY 2020: -54.4%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 1612.9%FY 2024: -77.1%FY 2025: -100.0%
FY 2019 FY 2025
Operating Income 51.3%
FY 2019: 0.0%FY 2020: -187.8%FY 2021: -112.0%FY 2022: -143.5%FY 2023: 119.3%FY 2024: -911.1%FY 2025: 51.3%
FY 2019 FY 2025
EPS (diluted) 65.5%
FY 2019: 0.0%FY 2020: -203.8%FY 2021: -92.4%FY 2022: -96.1%FY 2023: 123.5%FY 2024: -732.9%FY 2025: 65.5%
FY 2019 FY 2025
Free Cash Flow 26.4%
FY 2019: 0.0%FY 2020: -244.8%FY 2021: -104.0%FY 2022: -142.7%FY 2023: 105.9%FY 2024: -1671.5%FY 2025: 26.4%
FY 2019 FY 2025

Financial Health

Current Ratio 14.3×
FY 2019: 0.7×FY 2020: 1.9×FY 2021: 6.0×FY 2022: 8.2×FY 2023: 5.7×FY 2024: 6.7×FY 2025: 14.3×
FY 2019 5y median 6.7× FY 2025
Quick Ratio 14.3×
FY 2019: 0.7×FY 2020: 1.9×FY 2021: 6.0×FY 2022: 8.0×FY 2023: 5.2×FY 2024: 6.7×FY 2025: 14.3×
FY 2019 5y median 6.7× FY 2025
Debt / Equity 0.0×
FY 2019: -0.6×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.5×
FY 2019: 10.7×FY 2020: 0.3×FY 2021: 0.6×FY 2022: 0.3×FY 2023: -3.0×FY 2024: 0.3×FY 2025: 1.5×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019: -10.6×FY 2020: -17.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31